梅斯医学**采访第六届中华颈动脉外科高峰论坛大会主席曲乐丰教授

2017-04-19 MedSci MedSci原创

点击打开曲乐丰教授独家采访视频

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1843452, encodeId=8dd718434528b, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Dec 15 13:21:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662890, encodeId=a0c916628905a, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Fri Aug 04 18:21:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035068, encodeId=497320350683d, content=<a href='/topic/show?id=eca86021869' target=_blank style='color:#2F92EE;'>#曲乐丰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60218, encryptionId=eca86021869, topicName=曲乐丰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Wed Nov 01 05:21:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277007, encodeId=74f612e700735, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Apr 21 07:21:00 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1843452, encodeId=8dd718434528b, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Dec 15 13:21:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662890, encodeId=a0c916628905a, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Fri Aug 04 18:21:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035068, encodeId=497320350683d, content=<a href='/topic/show?id=eca86021869' target=_blank style='color:#2F92EE;'>#曲乐丰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60218, encryptionId=eca86021869, topicName=曲乐丰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Wed Nov 01 05:21:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277007, encodeId=74f612e700735, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Apr 21 07:21:00 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1843452, encodeId=8dd718434528b, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Dec 15 13:21:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662890, encodeId=a0c916628905a, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Fri Aug 04 18:21:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035068, encodeId=497320350683d, content=<a href='/topic/show?id=eca86021869' target=_blank style='color:#2F92EE;'>#曲乐丰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60218, encryptionId=eca86021869, topicName=曲乐丰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Wed Nov 01 05:21:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277007, encodeId=74f612e700735, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Apr 21 07:21:00 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1843452, encodeId=8dd718434528b, content=<a href='/topic/show?id=dab8100523bb' target=_blank style='color:#2F92EE;'>#颈动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100523, encryptionId=dab8100523bb, topicName=颈动脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Dec 15 13:21:00 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662890, encodeId=a0c916628905a, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Fri Aug 04 18:21:00 CST 2017, time=2017-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035068, encodeId=497320350683d, content=<a href='/topic/show?id=eca86021869' target=_blank style='color:#2F92EE;'>#曲乐丰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60218, encryptionId=eca86021869, topicName=曲乐丰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Wed Nov 01 05:21:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277007, encodeId=74f612e700735, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri Apr 21 07:21:00 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
    2017-04-21 一闲

相关资讯

梅斯作为媒体参与2017世界骨科创新大会暨“BonTech创新奖颁奖典礼”4月8日上海盛大召开

2017年4月8日-9日,由上海医药行业协会、枫林集团、上海万怡会展管理股份有限公司联合主办,世界3D打印技术产业联盟、医联和玖玖骨科协办,及北美脊柱外科学会(NASS),上海枫林联盟、上海医疗器械行业协会和上海医药商业行业协会,上海市生物医药行业协会等机构的大力支持下的“2017 世界骨科创新大会暨展览会(WOISE2017)”将在4月8日与9日在上海光大会展中心国际大酒店隆重召开。本届大会

广州五月:梅斯作为媒体参与CAOS2017国际课程整装待发

Are U Ready?! CAOS2017国际课程一网打尽,就看您想与哪位国际大师来一次面对面的深度交流!作为骨科医生的您,一定对北美脊柱协会(NASS),美国特种外科医院(HSS),法国骨科与创伤科协会(SOFCOT)这些组织不陌生。是不是也有无数次想放下一切,拿起护照,来次说走就走的学术之旅;是不是也梦想走进国际顶尖医院,让大师手把手教授临床手术技术;是不是也有很多关于骨科临床实践的疑问

梅斯医学作为媒体参与第六届中华颈动脉外科高峰论坛 暨国际颈动脉外科峰会(CCS2017) 2017中国微循环学会周围血管疾病 专业委员会学术年会

第六届中华颈动脉外科高峰论坛 暨国际颈动脉外科峰会(CCS2017) 2017中国微循环学会周围血管疾病 专业委员会学术年会

梅斯作为媒体参与2017世界骨科创新大会暨展览会4月8日上海盛大召开

2017世界骨科创新大会暨展览会4月8日上海盛大召开只需480元,观摩中美脊柱大师同台秀技! 2017年4月8日-9日,由上海医药行业协会、枫林集团、上海万怡会展管理股份有限公司联合主办,世界3D打印技术产业联盟和医联协办,及北美脊柱外科学会(NASS),上海枫林联盟、上海医疗器械行业协会和上海医药商业行业协会等机构的大力支持下的“2017 世界骨科创新大会暨展览会(WOISE2017)”将在

从今天开始,中国多了一家互联网骨科医院

3月19日,银川市举办了互联网医院集中签约仪式,在签约仪式上,“唯医”、“好大夫”、“丁香园”、“春雨医生”、“北大医信”等互联网医疗企业与银川市政府签约,进驻银川智慧互联网医院基地,此次签约仪式上,银川市又出台若干扶持互联网医院政策,也是创新最多、支持力度最大的政策支撑体系。 一四年深耕国内第一家骨科互联网平台落户银川在众多签约企业中,国内第一家专注于骨科领域的互联网医疗平台“唯医网”